The Global Sevoflurane, Isoflurane and Desflurane Market is projected to reach US$ 1.48 Billion by 2028, growing at a Compound Annual Growth Rate (CAGR) of 3.8% during the forecast period (2023–2028). This steady growth is driven by the rising global volume of surgical procedures, an aging population requiring more medical interventions, and the continuous demand for safe and effective inhalation anesthetics in hospital and ambulatory surgical center settings.

As healthcare systems worldwide prioritize patient safety and surgical efficiency, the focus intensifies on the key pharmaceutical companies that develop, manufacture, and supply these critical anesthetics. In this blog, we profile the Top 10 Companies in the Sevoflurane, Isoflurane and Desflurane Industry—a group of established innovators and emerging players shaping the future of perioperative care.

Download FREE Sample Report:
2023-2028 Global and Regional Sevoflurane, Isoflurane and Desflurane Industry Status and Prospects Professional Market – View in Detailed Research Report

---

🔟 1. AbbVie Inc.

Headquarters: North Chicago, Illinois, USA
Key Offering: Sevoflurane (branded and generic)

AbbVie, following its acquisition of Allergan, possesses a robust portfolio that includes key hospital products like Sevoflurane. The company is a major supplier of this inhalation anesthetic, known for its rapid onset and offset, making it ideal for a wide range of surgical procedures.

Innovation and Market Initiatives:

• Focus on securing and expanding manufacturing capacity for essential hospital drugs

• Investment in supply chain resilience for critical care medicines

• Strategic positioning within the hospital pharmacy segment

---

9️⃣ 2. Baxter International Inc.

Headquarters: Deerfield, Illinois, USA
Key Offering: Sevoflurane, Isoflurane

Baxter is a global leader in hospital products, including a comprehensive range of inhalation anesthetics. Their critical product portfolio supports anesthesia providers in operating rooms worldwide, emphasizing product quality and reliable supply.

Innovation and Market Initiatives:

• Diversified manufacturing footprint to mitigate supply chain risks

• Commitment to providing high-quality, essential generic medications

---

8️⃣ 3. Lunan Pharmaceutical Group

Headquarters: Linyi, Shandong, China
Key Offering: Sevoflurane

Lunan Pharmaceutical is a significant player in the Asian pharmaceutical market and a key manufacturer of Sevoflurane. The company plays a crucial role in supplying the growing demand for anesthetics within China and other emerging markets.

Innovation and Market Initiatives:

• Strong focus on research and development within the anesthesia segment

• Expansion of production capabilities to serve domestic and international markets

Download FREE Sample Report:
2023-2028 Global and Regional Sevoflurane, Isoflurane and Desflurane Industry Status and Prospects Professional Market – View in Detailed Research Report

---

7️⃣ 4. Jiangsu Hengrui Medicine Co., Ltd.

Headquarters: Lianyungang, Jiangsu, China
Key Offering: Sevoflurane

As one of China’s leading pharmaceutical companies with growing international ambitions, Jiangsu Hengrui Medicine has developed and commercializes Sevoflurane. The company is known for its significant investment in R&D and efforts to bring high-quality medicines to global markets.

Innovation and Market Initiatives:

• Aggressive investment in pharmaceutical R&D

• Strategic push for international regulatory approvals and market entry

---

6️⃣ 5. Piramal Enterprises Limited (Critical Care Division)

Headquarters: Mumbai, Maharashtra, India
Key Offering: Sevoflurane, Isoflurane, Desflurane

Piramal’s Critical Care division is a global player in the hospital generics space, offering one of the broadest portfolios of inhalation anesthetics. The company manufactures and markets these drugs across over 100 countries.

Innovation and Market Initiatives:

• Extensive global manufacturing network for injectables and inhalation anesthetics

• Focus on complex generics and niche therapy areas within critical care

---

5️⃣ 6. Halocarbon Products Corporation

Headquarters: North Augusta, South Carolina, USA
Key Offering: Sevoflurane, Isoflurane, Desflurane (Active Pharmaceutical Ingredients – API)

Halocarbon Products is a key manufacturer of the high-purity fluorocarbon compounds used as Active Pharmaceutical Ingredients (APIs) for inhalation anesthetics. The company supplies these critical ingredients to numerous pharmaceutical companies worldwide.

Innovation and Market Initiatives:

• Specialization in the synthesis of high-purity fluorinated compounds

• Essential role in the global supply chain for inhalation anesthetic APIs

---

4️⃣ 7. Maruishi Pharmaceutical Co., Ltd.

Headquarters: Osaka, Japan
Key Offering: Sevoflurane

Maruishi Pharmaceutical is a prominent Japanese company with a strong focus on anesthetics and respiratory diseases. It is a leading supplier of Sevoflurane within the Japanese market and has a growing presence in other Asian regions.

Innovation and Market Initiatives:

• Long-standing expertise in the anesthesia and perioperative care market

• Commitment to serving the specific needs of the Japanese healthcare system

---

3️⃣ 8. Hikma Pharmaceuticals PLC

Headquarters: London, United Kingdom
Key Offering: Injectable anesthetics and related hospital products

While primarily known for its injectable portfolio, Hikma is a major force in the global generic hospital market. Its presence and distribution network make it an important player in the broader anesthesia ecosystem, often partnering or competing in markets adjacent to inhalation anesthetics.

Innovation and Market Initiatives:

• Strong commercial footprint in the US, Middle East, and Europe

• Focus on broadening access to essential medicines

Download FREE Sample Report:
2023-2028 Global and Regional Sevoflurane, Isoflurane and Desflurane Industry Status and Prospects Professional Market – View in Detailed Research Report

---

2️⃣ 9. Fresenius Kabi AG

Headquarters: Bad Homburg, Germany
Key Offering: Intravenous anesthetics, infusion therapies

Fresenius Kabi is a global healthcare company that specializes in medicines and technologies for infusion, transfusion, and clinical nutrition. Its strong position in the hospital sector, particularly in operating rooms with its IV anesthesia products, places it within the competitive landscape of perioperative care providers.

Innovation and Market Initiatives:

• Integrated portfolio of drugs, devices, and nutrition for clinical care

• Global manufacturing and supply chain capabilities

---

1️⃣ 10. Troikaa Pharmaceuticals Ltd.

Headquarters: Ahmedabad, Gujarat, India
Key Offering: Novel drug delivery systems, niche formulations

Troikaa is an innovative Indian pharmaceutical company known for its patented drug delivery platforms. While not a direct manufacturer of the listed anesthetics, its focus on innovation in drug delivery and presence in hospital products makes it an emerging company to watch in the adjacent therapeutic space.

Innovation and Market Initiatives:

• Development of patented drug delivery technologies like “SNEDS”

• Focus on creating differentiated products in competitive markets

Get Full Report Here:
2023-2028 Global and Regional Sevoflurane, Isoflurane and Desflurane Industry Status and Prospects Professional Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Inhalation Anesthesia Is Precise and Accessible

The Sevoflurane, Isoflurane, and Desflurane market is characterized by stable demand underpinned by global surgical volumes. However, the industry is navigating challenges such as price pressures, generic competition, and the need for robust, resilient supply chains.

📈 Key Trends Shaping the Market:

• Increasing surgical procedures in emerging economies driving volume growth

• Growing preference for Sevoflurane due to its favorable pharmacokinetic profile

• Stringent regulatory oversight ensuring drug quality and supply chain integrity

• Consolidation among generic manufacturers influencing competitive dynamics

Get Full Report Here:
2023-2028 Global and Regional Sevoflurane, Isoflurane and Desflurane Industry Status and Prospects Professional Market – View in Detailed Research Report

The companies listed above are not only supplying essential anesthetics—they are integral to ensuring safe and effective surgical care for millions of patients worldwide.